Invention Grant
- Patent Title: Percutaneous nerve evaluation for sacral neuromodulation
-
Application No.: US17083774Application Date: 2020-10-29
-
Publication No.: US11648405B2Publication Date: 2023-05-16
- Inventor: Melanie Crites-Bachert
- Applicant: Melanie Crites-Bachert
- Applicant Address: US OR Gresham
- Assignee: Resolute 360, LLC
- Current Assignee: Resolute 360, LLC
- Current Assignee Address: US OR Happy Valley
- Agency: Fleit Intellectual Property Law
- Agent Jon Gibbons
- Main IPC: A61B17/34
- IPC: A61B17/34 ; A61N1/372 ; A61N1/36 ; A61N1/05 ; A61B90/00

Abstract:
Practitioners who use sacral neuromodulation on a regular basis have sought ways to simplify the procedure and performing percutaneous nerve evaluations in the office setting have become increasingly more popular. However, many practitioners are limited by the lack of availability of fluoroscopy in the office setting and do not feel comfortable executing the procedure without it, for a variety of reasons. The disclosed system and method demonstrate an avenue to circumvent the lack of fluoroscopic guidance in the office setting enabling execution of percutaneous nerve evaluations successfully and efficiently.
Public/Granted literature
- US20210128926A1 PERCUTANEOUS NERVE EVALUATION FOR SACRAL NEUROMODULATION Public/Granted day:2021-05-06
Information query